The current treatment strategy for gouty arthritis
Febuxostat is a non-purine selective inhibitor of isoforms of xanthine oxidoreductase (XOR), the effect of which is aimed at lowering the level of serum uric acid (UA). Febuxostat is a more potent inhibitor of XOR than allopurinol, as confirmed by that target UA levels have been achieved more freque...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
IMA-PRESS LLC
2018-09-01
|
| Schriftenreihe: | Современная ревматология |
| Schlagworte: | |
| Online-Zugang: | https://mrj.ima-press.net/mrj/article/view/844 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|